PALB2 and Wilms tumor: Adank et al screened a random cohort of 47 Dutch Wilms tumor patients for germline mutations in PALB2 by DNA sequencing and Multiplex Ligation-dependent Probe Amplification and they did not identify any bi-allelic pathogenic mutations [23].